Health technology assessment on cervical cancer screening, 2000-2014.

作者: Betsy J. Lahue , Eva Baginska , Sophia S. Li , Monika Parisi

DOI: 10.1017/S0266462315000197

关键词: Health technologyFamily medicineCervical cancerPathologyMass screeningMEDLINEMetric (unit)NiceCervical screeningMedicineAlternative medicine

摘要: Objectives: The aim of this study was to conduct a review health technology assessments (HTAs) in cervical cancer screening highlight the most common metrics HTA agencies use evaluate and recommend technologies. Methods: Center for Reviews Dissemination (CRD), MedLine, national agency databases were searched using keywords (“cervical screening” OR “cervical cancer” screening”) “HTA” from January 2000 October 2014. Non-English language reports without English summaries, non-HTA reports, HTAs unrelated intervention sufficient summaries available online excluded. We used various National Institute Health Care Excellence (NICE) methods extract key assessment criteria determine whether change practice recommended. Results: One hundred ten unique identified; forty-four seventeen countries met inclusion criteria. All evaluated technologies among women. Ten identified either as an or comparator. outcome metric diagnostic accuracy, followed by economic effectiveness. Additional such adjunct testing, intervals, age-specific testing commonly evaluated. Nearly one-third (fifteen forty-four) recommended practice. Conclusions: This highlights popular screening. Clinical effectiveness have been consistently assessed HTAs, while became increasingly prevalent after 2007. Moreover, we observed increase optimized recommendations

参考文章(30)
Maccallini, Calvia M, Sideri M, Ronco G, Zorzi M, Giorgi Rossi P, Confortini M, Segnan N, Naldoni C, Zappa M, [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening]. Epidemiologia e prevenzione. ,vol. 36, ,(2012)
Maria Calvia, Chris J L M Mejier, Marc Arbyn, Jack Cuzick, Mario Sideri, Guglielmo Ronco, Anna Gillio Tos, Gabriele Accetta, Marco Zappa, Manuel Zorzi, Francesca Carozzi, Annibale Biggeri, Peter J F Snijders, Massimo Confortini, Nereo Segnan, Carlo Naldoni, Paolo Giorgi Rossi, Livia Giordano, Carla Cogo, [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors]. Epidemiologia e prevenzione. ,vol. 36, ,(2012)
Nocon M, Willich Sn, Greiner W, von der Schulenburg Jm, Mittendorf T, Roll S, Review on the medical and health economic evidence for an inclusion of colposcopy in primary screening programs for cervical cancer. GMS health technology assessment. ,vol. 3, ,(2007)
Paolo Giorgi Rossi, Luca Moresco, Paolo Della Palma, [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening]. Epidemiologia e prevenzione. ,vol. 36, ,(2012)
Nick Payne, J Chilcott, Euphemia McGoogan, Liquid-based Cytology in Cervical Screening: A Rapid and Systematic Review Health Technology Assessment. ,vol. 4, pp. 1- 73 ,(2000) , 10.3310/HTA4180
Mühlberger N, Nocon M, Mittendorf T, Siebert U, Willich Sn, Sroczynski G, von der Schulenburg Jm, Roll S, Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervical GMS health technology assessment. ,vol. 3, ,(2007)
Shalini L Kulasingam, Laura Havrilesky, Evan R Myers, Rahel Ghebre, Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force Agency for Healthcare Research and Quality (US). ,(2011)
TG Pavey, N Anokye, AH Taylor, P Trueman, T Moxham, KR Fox, M Hillsdon, C Green, JL Campbell, C Foster, N Mutrie, J Searle, RS Taylor, The Clinical Effectiveness and Cost-Effectiveness of Exercise Referral Schemes: A Systematic Review and Economic Evaluation Health Technology Assessment. ,vol. 15, pp. 1- 254 ,(2011) , 10.3310/HTA15440
Henry C Kitchener, Karen Canfell, Clare Gilham, Alexandra Sargent, Chris Roberts, Mina Desai, Julian Peto, The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. Health Technology Assessment. ,vol. 18, pp. 1- 196 ,(2014) , 10.3310/HTA18230